Thierry Andr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trifluridine/Tipiracil Plus Bevacizumab Provides Potential First-Line Alternative to Bevacizumab/Capecitabine in mCRC

Thierry André, MD, discusses the investigation of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer, including how its use as a standard of care in the third line supported its investigation in the first-line setting, the regimen’s efficacy and safety in the SOLSTICE trial, and the importance of this combination for patients in this space despite negative trial results.

France generalSaint antoineThierry andrDepartment of medical oncologySorbonne universityMedical oncologySaint antoine hospitalNew england journalColorectal cancer

GSK s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours

GSK s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

France generalEmma walmsleyThierry andrHal barronAxel hoosSorbonne universityDrug administrationMedical oncologySaint antoine hospital

Trifluridine/Tipiracil Combination Misses Mark in Metastatic Colon Cancer

No improvement in PFS versus standard for older patients ineligible for intensive therapy

France generalDemetris papamichaelThierry andrCharles bankheadSorbonne universityEuropean society for medical oncology virtual plenaryCyprus oncology centerEuropean society for medical oncologySaint antoine hospitalEuropean societyMedical oncologyMedpage todayMedical oncology virtual

Servier announces outcome from the primary analysis of the Phase III SOLSTICE trial assessing LONSURF (trifluridine/tipiracil) + bevacizumab in a 1st line setting for patients with unresectable mCRC non-eligible for intensive therapy

Servier, a global independent pharmaceutical group, announced today that the primary objective (progression free survival) of the Phase III SOLSTICE trial has not been met. SOLSTICE was designed to evaluate

Saint antoineUnited statesFrance generalKostenloser wertpapierhandelThierry andrPatrick therasseSonia marquesTaiho pharmaceutical co ltdServier groupWorld health organisationLate stageLife cycle managementDeputy head oncologyImmuno oncology therapeutic areaProfessor thierry andrSaint antoine hospital

Immunothérapie: en France, un accès parfois difficile à ces innovations

Immunothérapie: en France, un accès parfois difficile à ces innovations
lefigaro.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lefigaro.fr Daily Mail and Mail on Sunday newspapers.

United statesThierry andrAgency europeanGold stateAgency european thisஒன்றுபட்டது மாநிலங்களில்தியரி அன்றுதங்கம் நிலை